Armata Pharmaceuticals, Inc. (ARMP)

Last Closing Price: 14.80 (2026-04-21)

Net Income (Quarterly)

Net Income: Company's net profit or loss after all revenues, income items, and expenses have been accounted for. Because this figure is given after preferred dividend expense, it is the net income value allotted to common shareholders.

Armata Pharmaceuticals, Inc. (ARMP) had Net Income of $-124.30M for the most recently reported fiscal quarter, ending 2025-12-31.

Figures for fiscal quarter ending 2025-12-31
Income Statement Financials
$1.08M
Net Income
$-124.30M
--
$1.08M
$14.91M
$-13.82M
$-110.47M
$-124.30M
$-124.30M
$-124.30M
$-124.30M
$-124.30M
$-124.30M
$-13.82M
$-13.40M
36.24M
36.24M
$-3.43
$-3.41
Balance Sheet Financials
$10.67M
$12.19M
$66.21M
$76.88M
$8.95M
$256.92M
$286.53M
$295.48M
$-218.60M
$-222.09M
$-218.60M
36.43M
Cash Flow Statement Financials
$-25.76M
$-0.54M
$25.61M
$14.77M
$14.08M
$-0.69M
$2.61M
--
--
Fundamental Metrics & Ratios
1.19
--
--
6.70
-1.18
100.00%
-1274.01%
-1274.01%
--
-11456.04%
-11456.04%
$-26.30M
--
--
--
0.01
--
2.30
39.15
56.86%
55.97%
-161.67%
-324.33%
$-6.00
$-0.73
$-0.71